Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mitie shares surge on profit upgrade, £50m buyback

(Sharecast News) - Mitie shares soared on Monday as the cleaning-to-security services outsourcer upgraded its annual profit forecast and launched an extra £50m share buyback on the back of record revenues. Operating profits are now expected to rise by 23% to at least £200m compared with £162m a year earlier and a January forecast of at least £190m.

Revenue was expected to jump 11% to £4.5bn after a particularly strong final three months of 2023 where sales were up 10%. Shares in the company were up more than 7% in morning trade against a falling London market.

"We have continued to see sustained demand from our clients for transformational projects across their estates, driven by macro trends including decarbonisation, the modernisation of the built environment, and changes in the regulatory landscape," the company said in a trading update.

Hargreaves Lansdown analyst Susannah Streeter said the group had been making "significant strides" in keeping inflationary costs under control and turning its large pipeline of opportunities into contracts wins, with the UK government a key customer.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.